GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » NonCurrent Deferred Liabilities

ISU Abxis Co (XKRX:086890) NonCurrent Deferred Liabilities : ₩0 Mil (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is ISU Abxis Co NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

ISU Abxis Co's non-current deferred liabilities for the quarter that ended in Mar. 2025 was ₩0 Mil.

ISU Abxis Co NonCurrent Deferred Liabilities Historical Data

The historical data trend for ISU Abxis Co's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ISU Abxis Co NonCurrent Deferred Liabilities Chart

ISU Abxis Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ISU Abxis Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ISU Abxis Co NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of ISU Abxis Co's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


ISU Abxis Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
3Fl. Kookje Bldg, 90-1 Daeshin-dong, Seodaemun-gu, Seoul, KOR, 120-160
ISU Abxis Co Ltd is engaged in developing and manufacturing therapeutic antibodies in South Korea. It offers Abciximab, Clotinab, Abcertin, and Fabagal used to treat incurable diseases such as cancer and rare diseases.

ISU Abxis Co Headlines

No Headlines